The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Investigation of probiotics in multiple sclerosis
Open accessAbstract
None of the disease-modifying therapies (DMTs) currently being used for the management of multiple sclerosis (MS) are 100% effective. In addition, side effects associated with the use of these DMTs have limited the practice of combination therapy. Hence, there is a need for safe immunomodulatory agents to fine-tune the management of MS. The gut microbiome plays an important role in autoimmunity, and several studies have reported alterations in the gut microbiome of MS patients. Studies in animal model of MS have identified members of the gut commensal microflora that exacerbate or ameliorate neuroinflammation. Probiotics represent an oral, non-toxic immunomodulatory agent that could be used in combination with current MS therapy. We designed a pilot study to investigate the effect of VSL3 on the gut microbiome and peripheral immune system function in healthy controls and MS patients. VSL3 administration was associated with increased abundance of many taxa with enriched taxa predominated by Lactobacillus, Streptococcus, and Bifidobacterium species. At the immune level, VSL3 administration induced an anti-inflammatory peripheral immune response characterized by decreased frequency of intermediate monocytes (CD14 high CD16 low ), decreased mean fluorescence intensity (MFI) of CD80 on classical monocytes as well as decreased human leukocyte antigen–antigen D related (HLA-DR) MFI on dendritic cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, probiotics supplementations have a therapeutic potential to ameliorate MS, improving the disability status, the mental health, and some inflammatory and metabolic parameters, compared to the placebo group (148, 149).”
From The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology (2020) · cites this paper as [149]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
A new method for non-parametric multivariate analysis of variance
Anderson, M. J. (2001) · Austral Ecology · doi:10.1111/j.1442-9993.2001.01070.pp.x · Cited by 13,828
Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms
Caporaso, J. G., Lauber, C. L., Walters, W. A., Berg-Lyons, D., Huntley, J., Fierer, N., Owens, S. M., Betley, J., Fraser, L., Bauer, M., et al. (2012) · The ISME Journal · doi:10.1038/ismej.2012.8 · Cited by 8,839
SortMeRNA: fast and accurate filtering of ribosomal RNAs in metatranscriptomic data
Kopylova, E., Noé, L., & Touzet, H. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts611 · Cited by 3,051
Zhang, X., Zhang, D., Jia, H., Feng, Q., Wang, D., Liang, D., Wu, X., Li, J., Tang, L., Li, Y., et al. (2015) · Nature Medicine · doi:10.1038/nm.3914 · Cited by 1,690
Rothhammer, V., Mascanfroni, I. D., Bunse, L., Takenaka, M. C., Kenison, J. E., Mayo, L., Chao, C.-C., Patel, B., Yan, R., Blain, M., et al. (2016) · Nature Medicine · doi:10.1038/nm.4106 · Cited by 1,559
Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis
Lee, Y. K., Menezes, J. S., Umesaki, Y., & Mazmanian, S. K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000082107 · Cited by 1,323
Alterations of the human gut microbiome in multiple sclerosis
Jangi, S., Gandhi, R., Cox, L. M., Li, N., von Glehn, F., Yan, R., Patel, B., Mazzola, M. A., Liu, S., Glanz, B. L., et al. (2016) · Nature Communications · doi:10.1038/ncomms12015 · Cited by 1,307
Self-citationCommensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination
Berer, K., Mues, M., Koutrolos, M., Rasbi, Z. A., Boziki, M., Johner, C., Wekerle, H., & Krishnamoorthy, G. (2011) · Nature · doi:10.1038/nature10554 · Cited by 1,251
Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial
Gionchetti, P., Rizzello, F., Helwig, U., Venturi, A., Lammers, K. M., Brigidi, P., Vitali, B., Poggioli, G., Miglioli, M., & Campieri, M. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00171-9 · Cited by 1,147
Research works printed but not linked: 1
- Anderson MJ, 2001, Austral Ecology, 26, 32
Cited by
Sorted by citations
Items 101–156 of 156
Olejnik, P., Buczma, K., Cudnoch‐Jędrzejewska, A., & Kasarełło, K. (2024) · Immunologic Research · doi:10.1007/s12026-024-09471-y · Cited by 9
Innovative microbial strategies in atopic dermatitis
Ma, J., Fang, Y., Hu, J., Li, S., Zeng, L., Chen, S., Li, Z., Meng, R., Yang, X., Zhang, F., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1605434 · Cited by 7
Gut Microbiome as Potential Therapeutics in Multiple Sclerosis
Zhu, W., Dykstra, K., Zhang, L., & Xia, Z. (2021) · Current Treatment Options in Neurology · doi:10.1007/s11940-021-00693-1 · Cited by 7
Dysbiosis and Therapeutic Modulation of the Gut Microbiota in Multiple Sclerosis: A Narrative Review
Memariani, M., & Memariani, H. (2025) · Health Science Reports · doi:10.1002/hsr2.71564 · Cited by 5
Gut microbiome-based prediction of autoimmune neuroinflammationPreprint
Steimle, A., Neumann, M., Grant, E. T., Willième, S., Sciscio, A. D., Parrish, A., Ollert, M. W., Miyauchi, E., Soga, T., Fukuda, S., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.14.536901 · Cited by 5
Human microbiome in post-acute COVID-19 syndrome (PACS)
Fallah, A., Sedighian, H., Kachuei, R., & Fooladi, A. A. I. (2024) · Current Research in Microbial Sciences · doi:10.1016/j.crmicr.2024.100324 · Cited by 6
Nezamzadeh, F., Masroor, A., Esmailkhani, A., & Bialvaei, A. Z. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.07.024 · Cited by 4
Bifidobacteria in disease: from head to toe
Zhang, W., Jia, Q., Han, M., Zhang, X., Guo, L., Sun, S., Yin, W., Bo, C., Han, R., & Sai, L. (2023) · Folia Microbiologica · doi:10.1007/s12223-023-01087-3 · Cited by 4
Lami, K. F., de Oliveira, V. F., & Batista, K. Z. S. (2021) · Research Society and Development · doi:10.33448/rsd-v10i4.14185 · Cited by 4
Understanding glial cells: Implications for multiple sclerosis pathogenesis and therapeutics
Lalmani, Y. S., & Deshmukh, R. R. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102961 · Cited by 3
Thalib, H. I., Fatima, N., Fakruddin, F. H., Ali, H. H., Khan, S. M., Zubair, M. T. M., Pereira, M., & Hassan, F. E. (2026) · Brain and Behavior · doi:10.1002/brb3.71254 · Cited by 4
Martini, S., Marino, F., Magistrelli, L., Contaldi, E., Cosentino, M., & Comi, C. (2023) · Pilot and Feasibility Studies · doi:10.1186/s40814-023-01306-1 · Cited by 5
Sriwastava, S., Beard, K., Amatya, S., Shrestha, K., Jaiswal, S., & Lisak, R. P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95343-6.00014-5 · Cited by 3
Disease of the holobiont, the example of multiple sclerosis
Castillo-Álvarez, F., & Marzo-Sola, M. E. (2019) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2018.08.012 · Cited by 3
Ghanei, N., Saghazadeh, A., & Rezaei, N. (2019) · Springer eBooks · doi:10.1007/978-3-030-16073-9_10 · Cited by 2
Wickstead, E. S., Elliott, B., Biggs, C. S., Getting, S. J., & McArthur, S. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.09.195198 · Cited by 2
Immunostimulatory Role of Prebiotics and Probiotics
Mohanty, T., Gurjar, B. P., Yangala, S. B., & Nagarajan, U. (2022) · doi:10.1002/9781394167227.ch7 · Cited by 2
Jarosz, Ł. S., Ciszewski, A., Marek, A., Hejdysz, M., Nowaczewski, S., Grądzki, Z., Michalak, K., Kwiecień, M., & Rysiak, A. (2022) · Food and Agricultural Immunology · doi:10.1080/09540105.2021.2006611 · Cited by 1
Potential role of probiotics for neurological disease treatment
Quadri, K., Kadian, R., Thakur, S., Chaturvedi, S., Rawat, G., Waziri, A., & Alam, M. S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15702-8.00030-0 · Cited by 1
Role of microbiota-gut-brain axis in autoimmunity and multiple sclerosis
Mishra, Y., Maity, D., & Kaundal, R. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-21680-0.00007-9 · Cited by 1
Exploring the Role of the Microbiome in Multiple Sclerosis
Kasper, L. H., Chitnis, T., Avila, M., Sconzo, N., Ashton, R., Ashton MediCom, S., & Rametta, M. (2019) · touchREVIEWS in Neurology · doi:10.17925/usn.2019.15.2.82 · Cited by 1
Gut Microbiota in Brain diseases
Salami, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00040-1
Microbiome Management of Neurological Disorders
Ortíz, G. G., Bitzer-Quintero, O. K., Niño, C. L. C., Ramírez-Jirano, L. J., González-Usigli, H., Pacheco-Moisés, F. P., Torres-Mendoza, B. M., Mireles-Ramírez, M. A., Hernández-Cruz, J. J., & Delgado-Lara, D. L. C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00003-6
Мінухін, В. В., Knysh, O. V., Ждамарова, Л. А., Bolshakova, H., & Voyda, Y. V. (2022) · Zaporozhye Medical Journal · doi:10.14739/2310-1210.2022.1.236932
The Role of Multiple Sclerosis Therapies on the Dynamic of Human Gut MicrobiotaPreprint
Văcăraș, V., Muresanu, D. F., Buzoianu, A. D., Nistor, C., Vesa, Ș. C., Paraschiv, A.-C., Botos-Vacaras, D., Văcăraș, C., & Vithoulkas, G. (2022) · Research Square · doi:10.21203/rs.3.rs-2075054/v1
The Role of Multiple Sclerosis Therapies on the Dynamic of Human Gut MicrobiotaPreprint
Văcăraș, V., Muresanu, D. F., Buzoianu, A. D., Nistor, C., Vesa, Ș. C., Paraschiv, A.-C., Botos-Vacaras, D., Văcăraș, C., & Vithoulkas, G. (2022) · Research Square · doi:10.21203/rs.3.rs-2075054/v2
Human Gut Microbiota in Multiple Sclerosis- Can We Change it?Preprint
Paraschiv, A.-C., Văcăraș, V., Nistor, C., Văcăraș, C., Strilciuc, Ș., & Muresanu, D. F. (2023) · Research Square · doi:10.21203/rs.3.rs-3072689/v1
Ren, L., Xu, D., Zhang, W., Wu, S., Yu, M., He, X., & Wei, Z. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4530808
Lu, Q., & Xin, Y. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23947-2.00008-4
The Effect of Probiotics and Microbiota on Nervous System and Mental Illnesses
Hossainpour, H., Khazaei, S., & Mahmoudi, H. (2024) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/0118715249315760240905043415
The impact of gut microbiome on neuro-autoimmune demyelinating diseases
Abolfazli, P., Nchama, C. N. A., & Lucke-Wold, B. P. (2024) · Academia Biology · doi:10.20935/acadbiol7397
Feghhi, Z., Khorasgani, M. R., Hadjighassem, M., Esmaeili, H., & Zarkesh‐Esfahani, S. H. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10438-6
Gut microbiome related therapeutics and dietary supplements
Dhapola, R., Kumari, S., Sharma, P., Vellingiri, B., & HariKrishnaReddy, D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29932-2.00008-6
Khorasani, S., Faraji, F., Alaei, A., Nahayati, M., Tabasi, N. S., Forghani, N., Arab, F. L., & Mahmoudi, M. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-026-11256-8
The Effect of Probiotics on Mental Health
Yılmaz, G. G. (2025) · Nutritional neurosciences · doi:10.1007/978-981-95-1414-4_12
Montgomery, T. L., Eckstrom, K. M., Lile, K. H., Caldwell, S. K., Heney, E. R., Lahue, K. G., D’Alessandro, A., Wargo, M. J., & Krementsov, D. N. (2022) · Figshare · doi:10.6084/m9.figshare.21622034
Montgomery, T. L., Eckstrom, K. M., Lile, K. H., Caldwell, S. K., Heney, E. R., Lahue, K. G., D’Alessandro, A., Wargo, M. J., & Krementsov, D. N. (2022) · Figshare · doi:10.6084/m9.figshare.21622055
Montgomery, T. L., Eckstrom, K. M., Lile, K. H., Caldwell, S. K., Heney, E. R., Lahue, K. G., D’Alessandro, A., Wargo, M. J., & Krementsov, D. N. (2022) · Figshare · doi:10.6084/m9.figshare.21622037
Montgomery, T. L., Eckstrom, K. M., Lile, K. H., Caldwell, S. K., Heney, E. R., Lahue, K. G., D’Alessandro, A., Wargo, M. J., & Krementsov, D. N. (2022) · Figshare · doi:10.6084/m9.figshare.21622043
Montgomery, T. L., Eckstrom, K. M., Lile, K. H., Caldwell, S. K., Heney, E. R., Lahue, K. G., D’Alessandro, A., Wargo, M. J., & Krementsov, D. N. (2022) · Figshare · doi:10.6084/m9.figshare.21622031
Montgomery, T. L., Eckstrom, K. M., Lile, K. H., Caldwell, S. K., Heney, E. R., Lahue, K. G., D’Alessandro, A., Wargo, M. J., & Krementsov, D. N. (2022) · Figshare · doi:10.6084/m9.figshare.21622052
Montgomery, T. L., Eckstrom, K. M., Lile, K. H., Caldwell, S. K., Heney, E. R., Lahue, K. G., D’Alessandro, A., Wargo, M. J., & Krementsov, D. N. (2022) · Figshare · doi:10.6084/m9.figshare.21622046
Montgomery, T. L., Eckstrom, K. M., Lile, K. H., Caldwell, S. K., Heney, E. R., Lahue, K. G., D’Alessandro, A., Wargo, M. J., & Krementsov, D. N. (2022) · Figshare · doi:10.6084/m9.figshare.21622049
Montgomery, T. L., Eckstrom, K. M., Lile, K. H., Caldwell, S. K., Heney, E. R., Lahue, K. G., D’Alessandro, A., Wargo, M. J., & Krementsov, D. N. (2022) · Figshare · doi:10.6084/m9.figshare.21622040
Przerwa, J. (2025) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.4(48).2025.4431 · Cited by 1
Madjirebaye, P., Penga, Z., Mueeda, A., Huang, T., Peng, F., Xiao, M., Liua, Z., Béchir, M., Allasra, Y., Xu, Y., et al. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10911-w · Cited by 1
Exploring the impact of gut microbiota on epilepsy pathogenesis in Krushinsky–Molodkina rats
Bidzhiev, A. Z., Краева, Л. А., Ivlev, A. P., Goncharova, A. R., & Бажанова, Е. Д. (2025) · Russian Journal of Infection and Immunity · doi:10.15789/2220-7619-eti-17934
Sarmento, A., Regen, T., Ferro, D., Ruiz-Moreno, Á., González-Torres, C., Carter, K., Shanmugavadivu, A., Waisman, A., Sá, M. J., & Úbeda, C. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.23.707375
The Microbiome-Body Connection: Unraveling the Gut-Brain Axis
Islam, M. M., Mahbub, N. U., & Islam, M. A. (2026) · Springer eBooks · doi:10.1007/978-981-95-7494-0_1
Gut microbiota and brain health: Disease-specific pathways and emerging therapeutic strategies
Oriquat, G., Rizaev, J., Abdulqader, A. F., Kadhim, A. A., Jamuna, K. V., Singhal, D. K., Bainsal, N., & Mansurova, N. (2026) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2026.107407
Blanca-Serrano, T., Agredano-Sanchez, M., Gigosos, R. M. L., Navarro, M. F. J., González-Domenech, C. M., & Gutiérrez‐Bedmar, M. (2026) · Clinical Nutrition · doi:10.1016/j.clnu.2026.106747
Talaat, F., Elkattan, M., Sharaf, S. A., Hammad, E.-S., Hatem, G., & Hassan, T. M. (2026) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-026-01236-8
Gut microbiota in multiple sclerosis: immunological mechanisms and therapeutic implications
Niedziela, M., Maruszak, M., Wyżykowska, A., Grygorowicz, J., Faria, G., Mykhalevych, A., Sas-Wyżykowska, M., Blachucik, A., & Kryshtofik, A. (2026) · Aktualności Neurologiczne · doi:10.15557/an.2026.0008
Alshinnawy, A. S., Rashwan, E. A., Swelam, M. S., Mohamed, M. R., & Sayed, A. A. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08830-7
Multiple sclerosis occurrence with gut microbial metabolites and sex hormones
Sefat, M. P., Bahar, A., Mashhadi, M. J., Yosefi, S., Khazaei, M., & Tahmasebi, H. (2026) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2026.107973
Metadata
- Authors
- Tankou, S. K., Regev, K., Healy, B. C., Cox, L. M., Tjon, E., Kivisakk, P., Vanande, I. P., Cook, S., Gandhi, R., Glanz, B., Stankiewicz, J., & Weiner, H. L.
- Affiliations
- Brigham and Women's Hospital (US)
- Ann Romney Center for Neurologic Diseases, Evergrande Center for Immunologic Diseases, Partners Multiple Sclerosis Center, Brigham and Women’s Hospital and Department of Neurology, Harvard Medical School, Boston, MA, USA
- ORCID
- Venue
- Multiple Sclerosis Journal
- Publisher
- SAGE Publications
- Published
- 2018-01
- Volume
- 24
- Issue
- 1
- Pages
- 58-63
- ISSN
- 1352-4585 (ISSN-L)
- 1477-0970
- OpenAlex
- W2784311706
- Cited by
- 156
- References
- 25
- Citations by year
- 2026: 11 · 2025: 14 · 2024: 19 · 2023: 22 · 2022: 27 · 2021: 24 · 2020: 16 · 2019: 15 · 2018: 7
- FWCI
- 14.55
- Type
- journal article
- Language
- en
- Update notices
- correction (2018-11-27)
- Open access
- bronze
- doi.org
- Locations
- Multiple Sclerosis Journal (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Teva Pharmaceutical Industries
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- multiple sclerosis, probiotics, gut microbiota, immunomodulation, neuroinflammation, monocytes, dendritic cells, Lactobacillus, Streptococcus, Bifidobacterium, disease-modifying therapy, autoimmunity
- MeSH terms
- Gastrointestinal Microbiome, Adult, Female, Humans, Male, Middle Aged, Monocytes, Probiotics, Multiple Sclerosis, Relapsing-Remitting
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
